Clinical Trial Update: Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on Met DR in Type 2 Diabetes Mellitus patients evaluating plasma glucose and pharmacokinetics in Phase 1/Phase 2. The study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Met DR

Snippet

Sponsor: Elcelyx Therapeutics, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-04-07